Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/day: a randomized, double-blind, placebo-controlled, duloxetine-referenced study in the acute treatment of adult patients with major depressive disorder

This study assessed the efficacy, tolerability and safety of vortioxetine versus placebo in adults with recurrent major depressive disorder. This double-blind, randomized, placebo-controlled study included 608 patients [Montgomery–Åsberg Depression Rating Scale (MADRS) total score≥26 and Clinical Gl...

Descripción completa

Detalles Bibliográficos
Autores principales: Boulenger, Jean-Philippe, Loft, Henrik, Olsen, Christina Kurre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979887/
https://www.ncbi.nlm.nih.gov/pubmed/24257717
http://dx.doi.org/10.1097/YIC.0000000000000018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979887/
https://www.ncbi.nlm.nih.gov/pubmed/24257717
http://dx.doi.org/10.1097/YIC.0000000000000018

Ejemplares similares